ASCO 2009: advance of the blockbusters

June 18, 2009
Sales and Marketing ASCO, Cancer

Key highlights of the recent American Society of Clinical Oncology's 45th Annual Meeting in Florida saw current blockbusters advance standard …

Don’t pick on medicines in health service downturn, says ABPI’s Barker

June 18, 2009
Research and Development ASCO, Cancer

The UK's health service is heading for a severe financial shortfall and will have to consider limiting spending, including on …

Abbas Hussain

GSK to co-market generics with Dr. Reddy’s

June 17, 2009
Sales and Marketing Dr Reddy, GSK, em, generics

 GlaxoSmithKline will increase its reach into emerging markets with a new deal to co-market generics with Dr. Reddy’s.The Indian company …

Plavix to face six generic competitors in Europe

June 17, 2009
Sales and Marketing Plavix, Sanofi-Aventis

Plavix is to face competition from six generics in Europe, potentially decimating sales of Sanofi-Aventis' brand in the region. Plavix …

EC backs away from Directive on excipient GMP

June 17, 2009
Manufacturing and Production Europe, excipients

The European Commission has opted not to press ahead with developing a Directive on Good Manufacturing Practices for ‘certain’ pharmaceutical …

New PR association takes aim at digital promotion

June 17, 2009
Medical Communications, Sales and Marketing PR

A new PR body has been launched and tasked with shedding some light on how to promote healthcare clients online …

Lilly invites researchers to submit novel compounds online

June 16, 2009
Medical Communications, Research and Development digi, lilly

Lilly is launching a new web portal which it hopes will attract drug discovery researchers with promising new compounds. The …

Contract research sector: news in brief

June 16, 2009
Medical Communications CRO, mds

Pharmafocus presents a round-up of developments in the contract research sector, including CBI's acquisition of a peptide specialist, MDS Pharma …

Novartis cooks up first swine flu vaccine batch

June 16, 2009
Manufacturing and Production Novartis

Novartis is ready to press ahead with clinical trials of its candidate vaccine against influenza (A)H1N1, having completed manufacturing of …

Scaling up the UK’s research ambition

June 15, 2009
Research and Development NHS, clinical trials, healthcare, patients

The UK has always been one of the world's leaders in drug discovery, with around half of all major medicines …

Icon extends strategic contract from Lilly

June 15, 2009
Manufacturing and Production ICON

Irish contract research organisation Icon will manage clinical trial set-up and management for Lilly's European trials in a deal that …

NICE defies pressure and keeps restrictions on Alzheimer’s

June 15, 2009
Research and Development Alzheimer's, NICE

Patients with early stage Alzheimer's disease will still be denied access to drug treatment after NICE decided to retain its …

New health secretary promises ‘deep clean’ of NHS priorities

June 15, 2009
NHS, healthcare

The new health secretary Andy Burnham has promised a 'deep clean' of the NHS' priorities, with a further move away …

Battle ahead for US industry over biologics patents

June 12, 2009
Research and Development, Sales and Marketing PhRMA, US, generics, industry, reform

Moves to make it easier for biosimilars to be approved in the US are gaining momentum.The pharma industry has conceded …

Schering-Plough opens Dutch injectables facility

June 12, 2009
Manufacturing and Production Europe, Netherlands

Schering-Plough has opened a new pharmaceutical manufacturing facility in Oss, the Netherlands, to help meet demand for the drugmakers' injectable …

Pandemic declaration will not change UK’s response

June 12, 2009
NHS, h1n1

The Department of Health has insisted there will be no "material change" to the UK's preparations for swine flu. The …

Anti-smoking measures boosted by £2.5m grant

June 11, 2009
Cancer, NHS

Government anti-smoking measures are to receive a boost with the provision of a £2.5 million grant to help smokers kick …

Genentechlr

Genentech forms type I diabetes collaboration

June 11, 2009
Research and Development Roche, diabetes

 The deal gives the Roche-owned biotech development and marketing rights to Bayhill’s molecule BHT-3021, which is currently in phase I/II …

Time to find and develop your ‘Eureka!’ people

June 11, 2009
Business Services diversity, recruitment, training

The big pharma model is broken, and one of the ways drug development companies are going to fix it is …

The Gateway to Local Adoption Series

Latest content